Loading...
Market
Xaira to launch a marketable RFdiffusion product by 2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Company announcements or major biotech industry publications.
Story
Xaira, Led by CEO Marc Tessier-Lavigne, Raises $1B for RFdiffusion Tech
Apr 25, 2024, 12:25 AM
Xaira, a new biotechnology company, has successfully raised over $1 billion in committed capital, marking one of the largest funding rounds in biotech history. The company, led by CEO Marc Tessier-Lavigne, is set to focus on next-generation technology in biopharma, leveraging AI and RFdiffusion from David Baker's lab. The funding round saw participation from major venture capital firms including Arch, Foresite, F-Prime, NEA, Sequoia, Lux, Lightspeed, and Two Sigma. This significant financial backing underscores the growing interest and investment in tech-driven biopharma solutions.
View original story
Similar markets
Under $30 billion • 25%
$30 billion to $50 billion • 25%
$50 billion to $70 billion • 25%
Over $70 billion • 25%
Under $30 billion • 25%
$30 billion to $50 billion • 25%
$50 billion to $70 billion • 25%
Over $70 billion • 25%
Healthcare • 25%
Automotive • 25%
Finance • 25%
Entertainment • 25%